Search details
1.
In vivo HSC prime editing rescues sickle cell disease in a mouse model.
Blood
; 141(17): 2085-2099, 2023 04 27.
Article
in English
| MEDLINE | ID: mdl-36800642
2.
The diverse genetic origins of a Classical period Greek army.
Proc Natl Acad Sci U S A
; 119(41): e2205272119, 2022 10 11.
Article
in English
| MEDLINE | ID: mdl-36191217
3.
Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo.
Blood
; 138(17): 1540-1553, 2021 10 28.
Article
in English
| MEDLINE | ID: mdl-34086867
4.
Myasthenia gravis genome-wide association study implicates AGRN as a risk locus.
J Med Genet
; 59(8): 801-809, 2022 08.
Article
in English
| MEDLINE | ID: mdl-34400559
5.
Precision Editing as a Therapeutic Approach for ß-Hemoglobinopathies.
Int J Mol Sci
; 24(11)2023 May 31.
Article
in English
| MEDLINE | ID: mdl-37298481
6.
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes.
Int J Mol Sci
; 24(22)2023 Nov 07.
Article
in English
| MEDLINE | ID: mdl-38003218
7.
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Int J Mol Sci
; 25(1)2023 Dec 23.
Article
in English
| MEDLINE | ID: mdl-38203404
8.
In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model.
Mol Ther
; 29(2): 822-837, 2021 02 03.
Article
in English
| MEDLINE | ID: mdl-32949495
9.
Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
Clin Infect Dis
; 73(11): 2073-2082, 2021 12 06.
Article
in English
| MEDLINE | ID: mdl-33905481
10.
Non-transplantable cord blood units as a source for adoptive immunotherapy of leukaemia and a paradigm of circular economy in medicine.
Br J Haematol
; 194(1): 158-167, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34036576
11.
Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia.
Biol Blood Marrow Transplant
; 25(9): 1756-1760, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31128329
12.
Genetic history of the population of Crete.
Ann Hum Genet
; 83(6): 373-388, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31192450
13.
Aspergillus galactomannan detection: Trichoderma as a cause of positive results.
Curr Microbiol
; 76(1): 48-51, 2019 Jan.
Article
in English
| MEDLINE | ID: mdl-30310968
14.
The ex vivo toll-like receptor 7 tolerance induction in donor lymphocytes prevents murine acute graft-versus-host disease.
Cytotherapy
; 20(1): 149-164, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29150086
15.
Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.
Ann Hematol
; 97(10): 1987-1994, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-29869673
16.
Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Clin Transplant
; 32(9): e13371, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30080283
17.
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
J Clin Apher
; 33(6): 654-660, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30394564
18.
Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 23(3): 445-451, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-27914967
19.
Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent ß-thalassaemia of a severe genotype.
Br J Haematol
; 196(6): 1401-1404, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34957544
20.
Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy.
Blood
; 126(5): 616-9, 2015 Jul 30.
Article
in English
| MEDLINE | ID: mdl-26089395